Trial · NCT07889440
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Anatomical Zone of the Effective Coronary Sinus RF Application | During the index ablation procedure | Anatomical location of the first epicardial radiofrequency (RF) application within the coronary sinus that is temporally associated with achievement of bidirectional mitral isthmus conduction block. Unit: categorical variable (Superior, Anterior, Inferior, or Posterior zone). |
| Primary | RF Power of the Effective Coronary Sinus RF Application | During the index ablation procedure | RF power delivered during the first epicardial coronary sinus RF application that is temporally associated with achievement of bidirectional mitral isthmus conduction block. Unit: Watts (W). |
| Primary | Duration of the Effective Coronary Sinus RF Application | During the index ablation procedure | Duration of the first epicardial coronary sinus RF application that is temporally associated with achievement of bidirectional mitral isthmus conduction block. Unit: seconds (s). |
| Primary | Contact Force of the Effective Coronary Sinus RF Application | During the index ablation procedure | Mean contact force recorded during the first epicardial coronary sinus RF application that is temporally associated with achievement of bidirectional mitral isthmus conduction block. Unit: grams (g). |
| Primary | Ablation Index of the Effective Coronary Sinus RF Application | During the index ablation procedure | Ablation Index value of the first epicardial coronary sinus RF application that is temporally associated with achievement of bidirectional mitral isthmus conduction block. |
| Primary | Cumulative Epicardial RF Time to Mitral Isthmus Block | During the index ablation procedure | Total cumulative duration of epicardial coronary sinus RF applications delivered up to and including the first application associated with achievement of bidirectional mitral isthmus conduction block. Unit: seconds (s). |
| Primary | Relative Order of the Effective Coronary Sinus RF Application | During the index ablation procedure | Sequence number of the first epicardial coronary sinus RF application that is temporally associated with achievement of bidirectional mitral isthmus conduction block. Unit: lesion number (n). |
| Secondary | Number of Epicardial Coronary Sinus RF Applications | During the index ablation procedure | Total number of epicardial radiofrequency (RF) applications delivered within the coronary sinus during the ablation procedure. Unit: number of RF applications (n). |
| Secondary | Distribution of Epicardial Coronary Sinus RF Applications | During the index ablation procedure | Number of epicardial RF applications delivered within each of the 8 predefined anatomical coronary sinus zones. Unit: number of RF applications per anatomical zone (n). |
| Secondary | Cumulative Epicardial Coronary Sinus RF Time | During the index ablation procedure | Total cumulative duration of all epicardial RF applications delivered within the coronary sinus. Unit: seconds (s). |
| Secondary | Total Procedure RF Time | During the index ablation procedure | Total duration of radiofrequency energy delivery during the entire ablation procedure. Unit: seconds (s). |
| Secondary | Total Fluoroscopy Time | During the index ablation procedure | Total fluoroscopy time during the ablation procedure. Unit: minutes (min). |
| Secondary | Total Procedure Duration | During the index ablation procedure | Total duration of the ablation procedure. Unit: minutes (min). |
| Secondary | Achievement of Bidirectional Mitral Isthmus Block Without Epicardial Coronary Sinus Ablation | During the index ablation procedure | Proportion of procedures in which bidirectional mitral isthmus (MI) conduction block is achieved without delivery of epicardial RF applications within the coronary sinus. Unit: percentage of procedures (%). |
| Secondary | Number of Coronary Sinus RF Applications According to VOM-EI Success | During the index ablation procedure | Difference in the total number of epicardial coronary sinus RF applications between procedures with successful Vein of Marshall ethanol infusion (VOM-EI) and procedures with failed or absent VOM-EI. Unit: number of RF applications (n). |
| Secondary | Distribution of Coronary Sinus RF Applications According to VOM-EI Success | During the index ablation procedure | Difference in the distribution of epicardial coronary sinus RF applications across the 8 predefined anatomical zones between procedures with successful VOM-EI and procedures with failed or absent VOM-EI. Unit: number of RF applications per anatomical zone (n). |
| Secondary | Cumulative Epicardial RF Time According to VOM-EI Success | During the index ablation procedure | Difference in cumulative epicardial coronary sinus RF time between procedures with successful VOM-EI and procedures with failed or absent VOM-EI. Unit: seconds (s). |
| Secondary | Time to Mitral Isthmus Block According to VOM-EI Success | During the index ablation procedure | Difference in time to achievement of bidirectional mitral isthmus conduction block between procedures with successful VOM-EI and procedures with failed or absent VOM-EI. Unit: seconds (s). |
| Secondary | Incidence of Periprocedural Complications | During the index ablation procedure | Incidence of periprocedural complications related to mitral isthmus ablation, epicardial coronary sinus RF ablation, or Vein of Marshall ethanol infusion (VOM-EI), including pericardial effusion or cardiac tamponade, coronary sinus dissection or perforation, coronary artery injury or spasm, stroke or transient ischemic attack (TIA), phrenic nerve palsy, steam pop, and complications specifically related to VOM-EI. Unit: percentage of participants with at least one periprocedural complication (%). |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07889440/registered